| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-M00053801 | CTRPv2 | pan-cancer | AAC | -0.044 | 0.4 |
| mRNA | BMS-536924 | GDSC1000 | pan-cancer | AAC | -0.03 | 0.4 |
| mRNA | YL54 | CTRPv2 | pan-cancer | AAC | -0.035 | 0.4 |
| mRNA | ZSTK474 | CTRPv2 | pan-cancer | AAC | -0.034 | 0.4 |
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | 0.05 | 0.4 |
| mRNA | Ko-143 | CTRPv2 | pan-cancer | AAC | -0.033 | 0.4 |
| mRNA | JNJ-26854165 | CTRPv2 | pan-cancer | AAC | -0.031 | 0.4 |
| mRNA | EKB-569 | GDSC1000 | pan-cancer | AAC | -0.03 | 0.4 |
| mRNA | Bortezomib | CTRPv2 | pan-cancer | AAC | 0.031 | 0.4 |
| mRNA | IPA-3 | GDSC1000 | pan-cancer | AAC | -0.03 | 0.4 |